INTRAVITREAL BEVACIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION-Reference-Cited by-同舟云学术

INTRAVITREAL BEVACIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION

Published:2016-05 Issue:5 Volume:36 Page:859-867
ISSN:0275-004X
Container-title:Retina
language:en
Short-container-title:

Author:

Arevalo J. Fernando,Lasave Andres F.,Wu Lihteh,Acón Dhariana,Berrocal María H.,Diaz-Llopis Manuel,Gallego-Pinazo Roberto,Serrano Martin A.,Alezzandrini Arturo A.,Rojas Sergio,Maia Mauricio,Lujan Silvio

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology,General Medicine

Reference29 articles.

1. Ranibizumab versus verteporfin for neovascular age-related macular degeneration;Brown;N Engl J Med,2006

2. Ranibizumab for neovascular age-related macular degeneration;Rosenfeld;N Engl J Med,2006

3. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2;Bressler;Arch Ophthalmol,2001

4. Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies;Schmidt-Erfurth;Ophthalmology,2014

5. Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration;Rosenfeld;Ophthalmic Surg Lasers Imaging,2005

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial Intelligence-Based Disease Activity Monitoring to Personalized Neovascular Age-Related Macular Degeneration Treatment: A Feasibility Study;Ophthalmology Science;2024-11

2. The Effect of Blue-light Filtering Intraocular Lenses on the Development and Progression of Macular Atrophy in Eyes With Neovascular Age-related Macular Degeneration;American Journal of Ophthalmology;2024-10

3. Real-World 1-Year Outcomes of Treatment-Intensive Neovascular Age-Related Macular Degeneration Switched to Faricimab;Ophthalmology Retina;2024-07

4. LONG-TERM USE OF ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION;Retina;2024-02

5. RPE und Gentherapie;Das Retinale Pigmentepithel – Physiologie und Pathologie;2024